This inventor holds 1 USPTO granted patent. Top assignee: Leland Stanford Junior University. Active years: 2018.
Company Filing History:
Years Active: 2018
Title: Innovations in Myocardial Therapy by Mingming Zhao
Introduction
Mingming Zhao is an accomplished inventor based in Sunnyvale, California. He has made significant contributions to the field of myocardial therapy through his innovative work on engineered collagen matrices. His research focuses on developing solutions for patients with damaged hearts, showcasing his commitment to advancing medical technology.
Latest Patents
Mingming Zhao holds a patent for a groundbreaking invention titled "Engineered collagen matrices for myocardial therapy." This patent discloses a patch system designed for use in patients with heart damage. The patch consists of a biodegradable engineered collagen scaffold that provides structural support to the injured heart. It also incorporates therapeutic agents that are delivered directly to the heart. The scaffold is made from a dense collagen lamella produced by plastic compression, ensuring compatibility with the biomechanical properties of beating heart tissue. One notable therapeutic agent, Fstl1, has been shown to induce cardiomyocyte proliferation and enhance cardiac regeneration after injury. Additionally, the patch can be loaded with functionalized nanoparticles, allowing for multi-modal imaging capabilities in vivo. The patent also outlines a method for implanting the patch onto a patient's heart.
Career Highlights
Mingming Zhao is affiliated with Leland Stanford Junior University, where he continues to push the boundaries of research in myocardial therapy. His work has garnered attention for its potential to improve patient outcomes in cardiac care. With a focus on innovative solutions, Zhao's contributions are paving the way for future advancements in the field.
Collaborations
Mingming Zhao has collaborated with notable colleagues, including Pilar Ruiz-Lozano and Vahid Serpooshan. These partnerships have further enriched his research and expanded the impact of his work in myocardial therapy.
Conclusion
Mingming Zhao's innovative approach to engineered collagen matrices represents a significant advancement in myocardial therapy. His patent and ongoing research hold promise for improving the lives of patients with heart damage. Through his work, Zhao exemplifies the spirit of innovation in the medical field.